{ "model": { "rank": 5395, "code": "thing-q179217", "model_id": "vr.tr.blood-coagulation", "name": "blood coagulation", "purpose": "Enable an agent to recognise blood coagulation, assess evidence of its progression and regulation, and identify justified observations or actions without treating a laboratory result as a diagnosis.", "family": "Thing Registry", "category": "Activities and processes", "status": "research-draft", "kind": "thing", "plane": "ACT", "domain": "ACT.ACT", "industry": "", "version": "", "url": "/models/thing/q179217/", "tier": 2, "score": 67, "payload": { "layer": "wikidata", "aliases": [ "Developmental Haemostasis" ], "aliasCount": 1, "merged": 1, "knownIn": 67, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q179217", "url": "https://www.wikidata.org/wiki/Q179217", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-09T22:16:50Z", "providers": [ "Codex" ], "breadth": "recalled by Codex without web access - no source was read", "missingProviders": [], "pass": 2, "cost": { "grok": { "seconds": 24.2, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a0883d-b710-7be0-8f7b-5cbd2c823836\n--------\nuser\nDescribe what is already known about one registered thing. Answer as JSON only, no prose around it.\n\nThing: blood coagulation\nSense to describe: (none recorded)\nDomain code: ACT.ACT\nAlso known as: (none)\n\n\nContext for this batch of 1001 things:\n# Batch 005: 10", "usd": 0, "recall": true }, "codex": { "seconds": 69.6, "error": "Reading additional input from stdin...\nOpenAI Codex v0.153.4\n--------\nworkdir: R:\\02_PROJECTS\\02_Meta_Models_Platforms\\Ver.cy\\current\\thing-registry-backlog\nmodel: gpt-6-astra\nprovider: openai\napproval: never\nsandbox: read-only\nreasoning effort: none\nreasoning summaries: none\nsession id: 01a0883d-b71a-7393-9fc2-31277fdaa191\n--------\nuser\nYou are drafting a Vercy meta-model for one registered thing. Answer as JSON only, no prose around it.\n\nThing: blood coagulation\nRegistry id: vr.tr.blood-coagulation\nPlane / domain: ACT / ACT.ACT\nRegistry definition: (none recorded)\nNames folded into this entr" } } }, "metaModel": { "id": "THING-Q179217", "registryId": "vr.tr.blood-coagulation", "name": "blood coagulation", "version": "0.1.0-research.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "ACT.ACT" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q179217/", "model": { "registry_id": "vr.tr.blood-coagulation", "name": "blood coagulation", "purpose": "Enable an agent to recognise blood coagulation, assess evidence of its progression and regulation, and identify justified observations or actions without treating a laboratory result as a diagnosis.", "definition": "Blood coagulation is the regulated enzymatic process in which thrombin converts soluble fibrinogen into fibrin, which forms and stabilizes a blood clot in coordination with platelets and other components of haemostasis.", "scope_statement": "This model owns vr.tr.blood-coagulation in ACT / ACT.ACT: the biological process that generates thrombin and forms stabilised fibrin in blood, including initiation, propagation, containment and experimental observation; human physiology is the initial reference scope.", "in_scope": [ "Identification of coagulation episodes in vessels, tissues and collected blood", "Initiating stimuli, reaction surfaces and coagulation-factor interactions", "Thrombin generation, fibrin formation and fibrin stabilisation", "Physiological inhibition and spatial containment of coagulation", "Assay evidence, specimen conditions and uncertainty about process state", "Effects of documented exposures or interventions on coagulation" ], "out_of_scope": [ "Primary platelet adhesion and aggregation except their contribution to coagulation", "Vascular constriction and the complete haemostatic response", "Fibrinolysis except its interface with fibrin persistence", "Blood-clot anatomy and embolus movement as independent objects or processes", "Full disease models for haemophilia, thrombosis and disseminated intravascular coagulation", "Individual treatment selection, medication dosing and prescribing" ], "distinguishing_features": [ "Identify evidence of coagulation-factor activity and fibrin production; platelet aggregation alone does not establish coagulation.", "Distinguish the fibrin-forming process from haemostasis, whose endpoint is control of bleeding.", "Distinguish coagulation activity from thrombosis: record whether an intravascular thrombus exists rather than assigning that diagnosis from activation alone.", "Distinguish fibrin generation from fibrin breakdown, even when both occur during the same episode.", "Separate coagulation in a collected specimen from coagulation in the organism by recording collection conditions and observation location." ], "characteristics": [ { "name": "Biological and experimental setting", "kind": "category", "unit_or_values": "Species; in vivo, ex vivo or in vitro; whole blood, plasma or reconstituted system", "why_it_matters": "Determines which physiological interpretation an observation can support." }, { "name": "Episode location", "kind": "relation", "unit_or_values": "Linked vessel, injury site, tissue compartment, specimen or experimental chamber", "why_it_matters": "Separates local activity from systemic inference and specimen artefact." }, { "name": "Initiating stimulus", "kind": "category", "unit_or_values": "Tissue-factor exposure, contact activation, assay reagent, mixed or unknown", "why_it_matters": "Identifies how the episode began and whether its mechanism represents physiological or experimental conditions." }, { "name": "Observed process state", "kind": "state", "unit_or_values": "Initiation, amplification, propagation, fibrin formation, stabilisation, inhibited or indeterminate; overlapping states permitted", "why_it_matters": "Supports a time-dependent account without imposing a strictly linear sequence." }, { "name": "Factor availability and activity", "kind": "measurement", "unit_or_values": "Factor-specific concentration or activity in reported units, with method and reference interval", "why_it_matters": "Separates measured quantity from functional contribution." }, { "name": "Thrombin-generation profile", "kind": "measurement", "unit_or_values": "Lag time in minutes, peak thrombin in nmol/L and endogenous thrombin potential in nmol·min/L, where supported by the assay", "why_it_matters": "Records reaction kinetics beyond a single clotting endpoint." }, { "name": "Fibrin formation and stabilisation", "kind": "state", "unit_or_values": "Not assessed, formation detected, stabilisation demonstrated or indeterminate; include evidence method", "why_it_matters": "Prevents visible clot formation from automatically establishing fibrin stabilisation." }, { "name": "Clotting-assay result", "kind": "measurement", "unit_or_values": "PT, aPTT or thrombin time in seconds; INR dimensionless when applicable; assay-specific reference interval", "why_it_matters": "Makes laboratory observations comparable only within justified methodological limits." }, { "name": "Regulatory or treatment exposure", "kind": "relation", "unit_or_values": "Linked inhibitor, anticoagulant, replacement product or reversal intervention with exposure time", "why_it_matters": "Provides context for interpreting altered activity and serial results." } ], "affordances": [ "Classify an observation as coagulation activity, a neighbouring haemostatic process or unresolved evidence.", "Trace an episode from initiating stimulus through reaction surfaces to fibrin formation.", "Compare serial results while checking specimen, reagent and treatment comparability.", "Locate missing evidence needed to distinguish factor deficiency, inhibition and specimen interference.", "Link coagulation observations to related clot, disease and treatment models.", "Prepare evidence-qualified requests for further observation or expert review." ] }, "sources": [], "structure": { "bundles": [ { "id": "episode-and-boundaries", "name": "Episode and boundaries", "description": "Establish what counts as the coagulation process being modelled and where it occurs.", "rationale": "A clot, a bleeding event and a prolonged assay time are different observations and must not become interchangeable instances.", "layers": [ { "id": "process-identity", "name": "Process identity", "description": "Separate coagulation from adjacent processes and its resulting material.", "findings": [ { "id": "fibrin-forming-process", "name": "Fibrin-forming process", "description": "Record evidence for thrombin-mediated fibrin formation and distinguish it from the broader haemostatic response. [Physiological Haemostasis](https://www.ncbi.nlm.nih.gov/books/NBK534253/)", "questions": [ { "text": "What evidence identifies this observation as blood coagulation rather than platelet aggregation alone?", "kind": "definition", "id": "fibrin-forming-process-q01" }, { "text": "Does the record describe an active process, its fibrin product or a laboratory proxy?", "kind": "boundary", "id": "fibrin-forming-process-q02" } ] } ] }, { "id": "episode-context", "name": "Episode context", "description": "Anchor observations to a biological setting and time interval.", "findings": [ { "id": "site-and-observation-window", "name": "Site and observation window", "description": "Record species, anatomical or experimental compartment, trigger time and observation time.", "questions": [ { "text": "Did coagulation occur in a vessel, at an injury site or after sample collection?", "kind": "provenance", "id": "site-and-observation-window-q01" }, { "text": "What event defines the beginning of the episode, and which observation times are known?", "kind": "measurement", "id": "site-and-observation-window-q02" } ] } ] } ] }, { "id": "initiation-and-reaction-surfaces", "name": "Initiation and reaction surfaces", "description": "Represent the initiating stimulus and the surfaces supporting coagulation reactions.", "rationale": "The same factor measurements can have different implications depending on where reactions occur and how activation was initiated.", "layers": [ { "id": "activation-route", "name": "Activation route", "description": "Separate observed triggers from explanatory pathway labels.", "findings": [ { "id": "trigger-and-pathway-framework", "name": "Trigger and pathway framework", "description": "Record tissue-factor exposure, contact activation or experimental initiation, and identify whether the explanation uses cascade terminology or a cell-based account.", "questions": [ { "text": "What initiating stimulus was observed, added experimentally or merely inferred?", "kind": "provenance", "id": "trigger-and-pathway-framework-q01" }, { "text": "Are intrinsic and extrinsic pathway labels being used to explain an assay or an event in vivo?", "kind": "boundary", "id": "trigger-and-pathway-framework-q02" } ] } ] }, { "id": "surface-localisation", "name": "Surface localisation", "description": "Locate reaction complexes relative to cells and experimental phospholipids.", "findings": [ { "id": "surface-dependent-factor-function", "name": "Surface-dependent factor function", "description": "Record reaction location as well as factor activity: cell-based experiments show that localisation affects a factor's haemostatic contribution. [Cellular interactions in hemostasis](https://pubmed.ncbi.nlm.nih.gov/8904166/)", "questions": [ { "text": "Which cells or supplied phospholipid surfaces support the recorded reactions?", "kind": "provenance", "id": "surface-dependent-factor-function-q01" }, { "text": "What evidence supports transferring observations from this reaction surface to the biological setting of interest?", "kind": "boundary", "id": "surface-dependent-factor-function-q02" } ] } ] } ] }, { "id": "thrombin-and-fibrin-production", "name": "Thrombin and fibrin production", "description": "Track reaction progression and the formation of a stabilised fibrin network.", "rationale": "An agent must distinguish initiation, sustained enzymatic activity and the resulting fibrin structure.", "layers": [ { "id": "enzymatic-progression", "name": "Enzymatic progression", "description": "Describe factor participation and thrombin-generation kinetics.", "findings": [ { "id": "thrombin-generation-evidence", "name": "Thrombin-generation evidence", "description": "Record measured or inferred thrombin generation, relevant factor activities and the evidence supporting the assigned process stage.", "questions": [ { "text": "Is thrombin generation directly measured, inferred from another endpoint or unassessed?", "kind": "measurement", "id": "thrombin-generation-evidence-q01" }, { "text": "Which factor deficiencies, inhibitors or experimental conditions could explain the observed progression?", "kind": "boundary", "id": "thrombin-generation-evidence-q02" } ] } ] }, { "id": "fibrin-network", "name": "Fibrin network", "description": "Distinguish fibrin production from subsequent stabilisation.", "findings": [ { "id": "formation-and-crosslinking", "name": "Formation and crosslinking", "description": "Separate fibrinogen conversion, fibrin assembly and factor XIII-mediated crosslinking. [Physiological Haemostasis](https://www.ncbi.nlm.nih.gov/books/NBK534253/)", "questions": [ { "text": "Which observation establishes fibrin formation rather than an unspecified change in sample consistency?", "kind": "measurement", "id": "formation-and-crosslinking-q01" }, { "text": "Has fibrin crosslinking been assessed, or is stabilisation being inferred from clot appearance?", "kind": "measurement", "id": "formation-and-crosslinking-q02" } ] } ] } ] }, { "id": "containment-and-net-persistence", "name": "Containment and net persistence", "description": "Represent limits on coagulation activity and the interface with fibrin removal.", "rationale": "Fibrin present at one moment does not by itself reveal the rates of its generation, inhibition or breakdown.", "layers": [ { "id": "coagulation-inhibition", "name": "Coagulation inhibition", "description": "Record endogenous inhibitory mechanisms and the spatial extent of activation.", "findings": [ { "id": "regulatory-restraint", "name": "Regulatory restraint", "description": "Capture evidence concerning antithrombin, the protein C system, tissue factor pathway inhibitor and localisation of coagulation. [Physiological Haemostasis](https://www.ncbi.nlm.nih.gov/books/NBK534253/)", "questions": [ { "text": "Which endogenous inhibitory mechanisms were assessed, and by what method?", "kind": "measurement", "id": "regulatory-restraint-q01" }, { "text": "What evidence distinguishes local coagulation activity from activation across multiple sites?", "kind": "boundary", "id": "regulatory-restraint-q02" } ] } ] }, { "id": "formation-removal-interface", "name": "Formation-removal interface", "description": "Link fibrin production to independently represented breakdown and persistence.", "findings": [ { "id": "net-fibrin-observation", "name": "Net fibrin observation", "description": "Record whether evidence concerns new fibrin production, accumulated fibrin or degradation, and preserve uncertainty when these cannot be separated.", "questions": [ { "text": "Does the observation measure fibrin formation, fibrin degradation or their combined outcome?", "kind": "measurement", "id": "net-fibrin-observation-q01" }, { "text": "Which aspects of the episode require a linked fibrinolysis or thrombus model?", "kind": "boundary", "id": "net-fibrin-observation-q02" } ] } ] } ] }, { "id": "assays-and-action-evidence", "name": "Assays and action evidence", "description": "Connect laboratory observations and documented interventions to defensible interpretations.", "rationale": "Coagulation measurements depend on specimen preparation, assay design and exposure history; interpretation must retain those dependencies.", "layers": [ { "id": "assay-validity", "name": "Assay validity", "description": "Describe the specimen, activation method and measured endpoint before interpreting a result.", "findings": [ { "id": "endpoint-and-preanalytics", "name": "Endpoint and preanalytics", "description": "Record collection conditions, sample handling, reagents, instruments and reference intervals. PT, aPTT and thrombin time measure time to fibrin formation under different activation conditions. [Coagulation Tests](https://ncbi.nlm.nih.gov/books/NBK265/)", "questions": [ { "text": "What specimen, reagent and endpoint produced this result, and what reference interval applies?", "kind": "provenance", "id": "endpoint-and-preanalytics-q01" }, { "text": "Were tube filling, processing delay, contamination and specimen clotting assessed before interpretation?", "kind": "measurement", "id": "endpoint-and-preanalytics-q02" }, { "text": "What conclusions about coagulation in vivo remain unsupported by this assay?", "kind": "boundary", "id": "endpoint-and-preanalytics-q03" } ] } ] }, { "id": "intervention-and-review", "name": "Intervention and review", "description": "Relate changes to exposure timing and identify justified next observations.", "findings": [ { "id": "exposure-aware-next-step", "name": "Exposure-aware next step", "description": "Link anticoagulant exposure, factor replacement or reversal to serial observations without assigning causation solely from temporal association.", "questions": [ { "text": "Which relevant exposures occurred before sampling, and how certain are their timing and identity?", "kind": "provenance", "id": "exposure-aware-next-step-q01" }, { "text": "What additional evidence would distinguish a biological change from assay interference or specimen error?", "kind": "action", "id": "exposure-aware-next-step-q02" }, { "text": "Does the available evidence justify a repeat observation, a linked disease assessment or expert review?", "kind": "action", "id": "exposure-aware-next-step-q03" } ] } ] } ] }, { "id": "evidence-and-external-alignment", "name": "Evidence and external alignment", "description": "What the world already says about this thing, gathered so the model can be checked against it.", "rationale": "A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.", "layers": [ { "id": "reported-evidence", "name": "Reported evidence", "description": "Findings from the breadth pass, kept separate from the structural claims.", "findings": [ { "id": "evidence-confidence-notes", "name": "Check these first", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "This describes the physiological process in humans and other mammals, not generic coagulation of colloids; details differ across animal groups.", "The traditional intrinsic, extrinsic and common pathways are useful laboratory teaching categories, but physiological coagulation is better understood as interacting reactions on cellular surfaces.", "Recalled reference intervals are illustrative, not treatment targets or diagnostic thresholds; verify local assay ranges and the precise WHO document before formal publication." ], "questions": [ { "id": "evidence-confidence-notes-q01", "text": "Which of these check these first hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-kinds", "name": "Kinds and varieties", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Physiological coagulation contributing to haemostasis after vascular injury", "Pathological coagulation contributing to thrombosis", "Coagulation outside the body in collected blood" ], "questions": [ { "id": "evidence-kinds-q01", "text": "Which of these kinds and varieties hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-identifiers", "name": "Identifiers and schemes", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "scheme": "Gene Ontology", "value_or_pattern": "GO:0007596", "note": "Biological process term for blood coagulation." } ], "questions": [ { "id": "evidence-identifiers-q01", "text": "Which of these identifiers and schemes hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-standards-and-regulation", "name": "Standards and regulation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "World Health Organization guidance and international reference preparations support thromboplastin calibration and standardization of prothrombin-time results using the international normalized ratio (INR)." ], "questions": [ { "id": "evidence-standards-and-regulation-q01", "text": "Which of these standards and regulation hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-real-world-use", "name": "Real-world use", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Stopping bleeding and stabilizing the initial platelet plug after vascular injury", "Evaluating bleeding disorders and deficiencies of coagulation factors", "Monitoring selected anticoagulant treatments with appropriate laboratory assays", "Assessing coagulation during major bleeding, surgery and transfusion", "Developing haemostatic treatments and antithrombotic medicines" ], "questions": [ { "id": "evidence-real-world-use-q01", "text": "Which of these real-world use hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-measurements", "name": "Typical measurements", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "quantity": "Prothrombin time (PT)", "typical_range": "Approximately 11-14 in healthy adults; reagent and laboratory dependent", "unit": "s" }, { "quantity": "Activated partial thromboplastin time (aPTT)", "typical_range": "Approximately 25-35 in healthy adults; reagent and laboratory dependent", "unit": "s" }, { "quantity": "International normalized ratio (INR)", "typical_range": "Approximately 0.8-1.2 in people not receiving vitamin K antagonists", "unit": "dimensionless" }, { "quantity": "Plasma fibrinogen concentration", "typical_range": "Approximately 2-4 in healthy adults; method and population dependent", "unit": "g/L" } ], "questions": [ { "id": "evidence-measurements-q01", "text": "Which of these typical measurements hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-failure-modes-and-hazards", "name": "Failure modes and hazards", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Insufficient coagulation from factor deficiencies or inhibitors can cause prolonged or spontaneous bleeding.", "Excessive or misplaced coagulation can produce thrombosis, obstruct blood flow and contribute to embolism.", "Disseminated intravascular coagulation can combine widespread microvascular clotting with consumption of platelets and coagulation factors, producing both organ injury and bleeding.", "Anticoagulant treatment can cause bleeding; inadequate anticoagulation in an indicated setting can leave thrombotic risk insufficiently controlled.", "Improper blood collection or handling can produce misleading coagulation-test results." ], "questions": [ { "id": "evidence-failure-modes-and-hazards-q01", "text": "Which of these failure modes and hazards hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-regional-variation", "name": "Regional variation", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ "Laboratories and jurisdictions differ in assay reagents, reporting conventions and reference intervals; INR provides specific standardization for vitamin K antagonist monitoring." ], "questions": [ { "id": "evidence-regional-variation-q01", "text": "Which of these regional variation hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] }, { "id": "evidence-neighbours", "name": "Neighbouring kinds and how to tell them apart", "description": "Recalled without web access and unsourced; every item is a lead to verify.", "evidence": [ { "name": "Haemostasis", "difference": "Haemostasis is the broader control of bleeding, including vascular responses, platelet activity and coagulation." }, { "name": "Platelet aggregation", "difference": "Platelet aggregation joins platelets into a plug; coagulation generates the fibrin that reinforces it." }, { "name": "Thrombosis", "difference": "Thrombosis is pathological clot formation within the circulation; coagulation is a process that also serves normal haemostasis." }, { "name": "Fibrinolysis", "difference": "Fibrinolysis breaks down fibrin, whereas coagulation generates and stabilizes it." }, { "name": "Blood clot", "difference": "A blood clot is the resulting material structure; blood coagulation is the process producing its fibrin component." } ], "questions": [ { "id": "evidence-neighbours-q01", "text": "Which of these neighbouring kinds and how to tell them apart hold for the sense of blood coagulation this model covers, and on what evidence?", "kind": "provenance" } ] } ] } ] } ] }, "openQuestions": [ "Which nonhuman species must the registry entry cover, and which mechanisms require species-specific extensions?", "Which operational criteria should distinguish initiation, propagation and containment across in vivo observations and different laboratory platforms?", "How should contact activation and inflammation-associated coagulation be represented across injury, artificial surfaces and pathological settings?", "Which assay-specific evidence is sufficient to infer impaired or excessive coagulation in a defined context, and where must the state remain indeterminate?", "Does an existing Vercy world model already own this process, requiring this registry entry to link to it instead of producing a separate publication?" ], "statistics": { "bundles": 6, "layers": 11, "findings": 19, "questions": 31 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a blood coagulation, record what state it is in, and decide what may be done with it.", "whatItIs": "Enable an agent to recognise blood coagulation, assess evidence of its progression and regulation, and identify justified observations or actions without treating a laboratory result as a diagnosis.", "characteristics": { "substance": "activity", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: Developmental Haemostasis.", "1 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 67 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a blood coagulation, and on what evidence are they told apart?" ], "whatItIsMadeOf": "something that happens over time", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "Developmental Haemostasis" ] } ], "standing": "Described in 67 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 1 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one blood coagulation from another, and a blood coagulation from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a blood coagulation sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a blood coagulation from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a blood coagulation passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a blood coagulation between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a blood coagulation, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a blood coagulation is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "process-and-outcome", "name": "Process, inputs and outcome", "description": "How a blood coagulation proceeds, what it needs and what it leaves behind.", "rationale": "An activity is known by its steps and its results, and both have to be recordable while it is still running.", "layers": [ { "id": "steps-and-sequence", "name": "Steps and sequence", "description": "The steps of a blood coagulation, their order and what may run in parallel.", "findings": [ { "id": "steps-and-preconditions", "name": "Steps, preconditions and completion", "description": "What has to be true before each step of a blood coagulation and what marks it done.", "questions": [ { "id": "steps-and-preconditions-q01", "text": "What identifies and describes a step of a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "steps-and-preconditions-q02", "text": "Who or what asserted this about a step of a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "steps-and-preconditions-q03", "text": "What may an agent decide or do once a step of a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "inputs-and-results", "name": "Inputs, resources and results", "description": "What a blood coagulation consumes and what it produces.", "findings": [ { "id": "inputs-and-outputs", "name": "Inputs, outputs and side effects", "description": "The resources a blood coagulation takes and the results it leaves, wanted or not.", "questions": [ { "id": "inputs-and-outputs-q01", "text": "What identifies and describes the inputs and results of a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "inputs-and-outputs-q02", "text": "Who or what asserted this about the inputs and results of a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "inputs-and-outputs-q03", "text": "What may an agent decide or do once the inputs and results of a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What blood coagulation is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of blood coagulation are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is blood coagulation operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of blood coagulation and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of blood coagulation?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as blood coagulation?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a blood coagulation came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a blood coagulation and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a blood coagulation is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a blood coagulation, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a blood coagulation, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a blood coagulation is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 6, "layers": 12, "findings": 14, "questions": 38 } } } }